Home / SLC29A1 Knockout Cell Lines

SLC29A1 Knockout Cell Lines

Gene: SLC29A1

Official Full Name: solute carrier family 29 member 1 (Augustine blood group)provided by HGNC

Gene Summary: This gene is a member of the equilibrative nucleoside transporter family. The gene encodes a transmembrane glycoprotein that localizes to the plasma and mitochondrial membranes and mediates the cellular uptake of nucleosides from the surrounding medium. The protein is categorized as an equilibrative (as opposed to concentrative) transporter that is sensitive to inhibition by nitrobenzylthioinosine (NBMPR). Nucleoside transporters are required for nucleotide synthesis in cells that lack de novo nucleoside synthesis pathways, and are also necessary for the uptake of cytotoxic nucleosides used for cancer and viral chemotherapies. Multiple alternatively spliced variants, encoding the same protein, have been found for this gene. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00465 SLC29A1 Knockout cell line (HEK293) Human SLC29A1 1:3~1:6 Negative Online Inquiry
KO38032 SLC29A1 Knockout cell line (HeLa) Human SLC29A1 1:3~1:6 Negative Online Inquiry
KO38033 SLC29A1 Knockout cell line (HCT 116) Human SLC29A1 1:2~1:4 Negative Online Inquiry
KO38034 SLC29A1 Knockout cell line (A549) Human SLC29A1 1:3~1:4 Negative Online Inquiry

Background

SLC29A1 Gene Knockout Cell Lines are genetically engineered cell lines designed to facilitate the study of the SLC29A1 gene, which encodes the concentrative nucleoside transporter 1 (CNT1). This gene is critical for the uptake of nucleosides and plays an essential role in nucleoside metabolism and cellular signaling. By utilizing CRISPR/Cas9 technology, these cell lines have been selectively disrupted for the SLC29A1 gene, allowing researchers to investigate the effects of its absence on cellular processes, drug metabolism, and sensitivity to nucleoside-based therapies.

The SLC29A1 knockout cell lines offer unique insights into the mechanisms of nucleoside transport and its implications for pharmacological responses. Through experimentation, researchers can elucidate how the absence of CNT1 affects the uptake of therapeutic agents, paving the way for the development of more effective drug delivery systems in oncology and virology. Such cell lines are invaluable for studying drug resistance mechanisms, particularly in cancers treated with nucleoside analogs, and can significantly advance our understanding of the pharmacokinetics of these agents.

One of our product's key advantages is its specific gene knockout, which is often more comprehensive than using pharmacological inhibitors that may have off-target effects. This specificity allows for more accurate assessments of gene function and interaction with drugs, making it a superior choice for those investigating nucleoside metabolism dynamics. Moreover, these cell lines are validated for consistent performance, ensuring reliability in experiments.

Our SLC29A1 Gene Knockout Cell Lines are indispensable tools for researchers and clinicians focused on drug development and personalized medicine. By providing precise and reliable models for the study of drug interactions and cellular responses, they empower scientists to make significant advancements in therapeutic strategies. With years of experience in producing high-quality biological products, our company is dedicated to supporting the scientific community in achieving groundbreaking discoveries.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.